Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Jones

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
Health Technology Assessment (Winchester, England)|September 11, 2024
Behaviour change intervention (education and text) to prevent dental caries in secondary school pupils: BRIGHT RCT, process and economic evaluationZoe Marshman, Hannah Ainsworth, Caroline Fairhurst, et al.
Frontiers in Cellular and Infection Microbiology|February 11, 2020
Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in ChildrenMichael J Carter, Pallavi Gurung, Claire Jones, et al.
Plos Neglected Tropical Diseases|October 20, 2020
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection modelMalick M Gibani, Celina Jin, Sonu Shrestha, et al.
Jac-Antimicrobial Resistance|May 21, 2025
Current status and future direction of antimicrobial stewardship programs and antibiotic prescribing in primary care hospitals in ZambiaFaustina Makiko, Aubrey Chichonyi Kalungia, Martin Kampamba, et al.
Plos Neglected Tropical Diseases|August 18, 2016
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21aThomas C Darton, Claire Jones, Christoph J Blohmke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2017
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge ModelHazel C Dobinson, Malick M Gibani, Claire Jones, et al.
Nature Medicine|July 5, 2019
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge modelMalick M Gibani, Elizabeth Jones, Amber Barton, et al.
The British Journal of Dermatology|November 25, 2023
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanomaTom Ewen, Akhtar Husain, Niki Stefanos, et al.
The Journal of Experimental Medicine|May 25, 2016
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid feverChristoph J Blohmke, Thomas C Darton, Claire Jones, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
Health Technology Assessment (Winchester, England)|September 11, 2024
Behaviour change intervention (education and text) to prevent dental caries in secondary school pupils: BRIGHT RCT, process and economic evaluationZoe Marshman, Hannah Ainsworth, Caroline Fairhurst, et al.
Frontiers in Cellular and Infection Microbiology|February 11, 2020
Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in ChildrenMichael J Carter, Pallavi Gurung, Claire Jones, et al.
Plos Neglected Tropical Diseases|October 20, 2020
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection modelMalick M Gibani, Celina Jin, Sonu Shrestha, et al.
Jac-Antimicrobial Resistance|May 21, 2025
Current status and future direction of antimicrobial stewardship programs and antibiotic prescribing in primary care hospitals in ZambiaFaustina Makiko, Aubrey Chichonyi Kalungia, Martin Kampamba, et al.
Plos Neglected Tropical Diseases|August 18, 2016
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21aThomas C Darton, Claire Jones, Christoph J Blohmke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2017
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge ModelHazel C Dobinson, Malick M Gibani, Claire Jones, et al.
Nature Medicine|July 5, 2019
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge modelMalick M Gibani, Elizabeth Jones, Amber Barton, et al.
The British Journal of Dermatology|November 25, 2023
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanomaTom Ewen, Akhtar Husain, Niki Stefanos, et al.
The Journal of Experimental Medicine|May 25, 2016
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid feverChristoph J Blohmke, Thomas C Darton, Claire Jones, et al.
Pageof 15